USRE45625E1 - Reading enhancement device for preventing and treating presbyopia of the eye - Google Patents
Reading enhancement device for preventing and treating presbyopia of the eye Download PDFInfo
- Publication number
- USRE45625E1 USRE45625E1 US14/266,677 US201414266677A USRE45625E US RE45625 E1 USRE45625 E1 US RE45625E1 US 201414266677 A US201414266677 A US 201414266677A US RE45625 E USRE45625 E US RE45625E
- Authority
- US
- United States
- Prior art keywords
- sclera
- suture
- center portion
- suture device
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related, expires
Links
- 201000010041 presbyopia Diseases 0.000 title claims abstract description 14
- 210000003786 sclera Anatomy 0.000 claims abstract description 88
- 230000006835 compression Effects 0.000 claims abstract description 44
- 238000007906 compression Methods 0.000 claims abstract description 44
- 210000004240 ciliary body Anatomy 0.000 claims abstract description 25
- 229920001059 synthetic polymer Polymers 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 229960005475 antiinfective agent Drugs 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 239000007769 metal material Substances 0.000 claims description 4
- 210000003205 muscle Anatomy 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims 10
- 210000004204 blood vessel Anatomy 0.000 claims 3
- 210000005036 nerve Anatomy 0.000 claims 3
- 210000004127 vitreous body Anatomy 0.000 abstract description 7
- 238000000034 method Methods 0.000 description 9
- 230000002411 adverse Effects 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 241000278713 Theora Species 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/145—Corneal inlays, onlays, or lenses for refractive correction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
Definitions
- This invention relates to a reading enhancement device sutured to the sclera of the eye for preventing and/or treating presbyopia and more particularly, but not by way of limitation, to a reading enhancement device for suturing to the outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera.
- Presbyopia is well known as a reduction or loss of nearsight, usually present in the fourth or fifth decade of a person's age.
- the subject enhancement device exerts a posterior compressive force or centripetal force directed toward the vitreous humor in the rear of the eye and behind the crystalline eye lens and eye lens bag.
- the compressive force is perpendicular to the plane of the sclera and provides for movement of the eye lens and eye lens bag forward along a line of vision for the correction of presbyopia.
- U.S. Pat. No. 6,682,560 to Baikoff an element for correcting presbyopia is described.
- the corrective element is implanted in a tunnel in the sclera and in line with the ciliary body of the eye.
- the element has a geometric design for exerting a centripetal force on the ciliary body at an angle perpendicular to the optical axis of the eye. While this type of corrective design can be used for treating phakic individuals, it will have no effect on treating pseudophakic individuals.
- the corrective element includes a rear wall for providing a pressure force oriented toward the center and the rear of the eye.
- Baikoff patent doesn't disclose or teach the importance of a reading enhancement device sutured to the outer wall of the sclera for directing an inward posterior compressive force perpendicular to the plane of the outer wall of the sclera.
- This key feature allows for the posterior compressive force to be directed behind the crystalline eye lens and eye lens bag for forward movement of the eye lens.
- Another object of the invention is to create posterior compressive forces perpendicular to a plane of the sclera and directed inwardly and readwardly behind the crystalline eye lens and eye lens bag for forward movement of the eye lens.
- Still another object of the reading enhancement device is the device's compression body is sutured directly to the outer wall of the sclera, so that a surgical incision in the sclera isn't necessary.
- This non-invasive procedure reduces the risk of infection and the length and cost of surgery. Also, because of this type of non-invasive procedure, there is less post operative pain and/or swelling and recovery time is reduced.
- Yet another object of the invention is the procedure doesn't create adverse eye effects such as capillary constriction, necrosis and macular edema. Also, the use of one or more of the reading enhancement devices is completely reversible with no long term adverse consequences.
- the present invention may be used for one or both eyes with one or more of the devices evenly spaced around the iris at the junction of the pars plana and the ora serrata.
- the enhancement devices may vary in size and thickness for correcting for varying amounts of functional loss. For example, a thicker device can be used to correct vision of a person with 3 diopters of loss and a thinner device can be used to correct the vision of a person with 1 diopter of loss.
- the subject reading enhancement device includes a compression body with a front of the body having semi-circular convex surface.
- the convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye.
- the compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon.
- the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion. The grooves and the enlarged, rounded first and second end portions are used to aid the eye surgeon in suturing and securing the enhancement device to the side of the eye.
- FIG. 1 is a front view of the subject reading enhancement device greatly enlarged and having an “I-beam” configuration.
- a front of the device includes a semi-circular convex surface used for engaging, buckling and compressing a portion of the sclera and ciliary body.
- FIG. 2 is an enlarged side view of the enhancement device.
- FIG. 3 is an enlarged end view of the enhancement device positioned next to a portion of the sclera and the ciliary body prior to suturing the device to the sclera.
- FIG. 4 is another enlarged end view of the enhancement device with the convex surface compressed against the sclera and the ciliary body and the device sutured thereto.
- FIG. 5 is an enlarged perspective view and cross-section of an eye illustrating an crystalline eye lens and eye lens bag with a line of vision, shown as a dashed arrow, centered thereon.
- two of the enhancement devices are shown positioned for suturing to the sclera and on opposite sides of the eye.
- FIG. 6 is another enlarged perspective view and cross-section of the eye illustrating the two enhancement devices sutured to the sclera.
- the two devices are disposed parallel to the plane of the outer wall of the sclera.
- the devices compress and buckle the sclera and the ciliary body inwardly, thus creating a posterior compressive force, shown as dashed arrows, inwardly toward the vitreous humor in the rear of the eye and perpendicular to the plane of the sclera.
- FIG. 7 is a perspective view of a portion of the sclera and illustrating an alternate way of securing the enhancement device to the sclera using a pair of sclera flaps cut in the outer wall of the sclera.
- FIG. 8 is another perspective view of the portion of the sclera with the sclera flaps folded on top of a portion of the enhancement device and sutured together.
- FIG. 1 a front view of the enlarged subject reading enhancement device is shown having general reference numeral 10 .
- the enhancement device 10 includes a compression body 11 with an “I-beam” configuration.
- a front 12 of the compression body 11 includes an outwardly extending semi-circular convex surface 14 .
- a side profile of the convex surface 14 is shown in FIG. 2 .
- the convex surface 14 is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye.
- the compression body 11 also includes an enlarged, rounded first end portion 16 , an enlarged, rounded second end portion 18 and an elongated center portion 20 with the convex surface 14 formed thereon.
- the enhancement device 10 typically has a length “L” in a range of 3 to 6 mm, a width “W” of 0.5 to 2.0 mm, a width “W 1 ” of 1.0 to 3.0 mm and a thickness “T”, shown in FIG. 2 , of the center portion 20 of 0.3 to 1.0 mm. Obviously, these dimension will vary depending on the eye application and method of engaging the side of the eye. Also, the device 10 can be made of either metallic or non-metallic materials, one or more different types of material, and treated with anti-infective or anti-inflammatory agents.
- FIG. 2 a side view of the enlarged enhancement device 10 is shown.
- the compression body 11 is shown with a rear 22 having an outwardly extending rib portion 24 having a pair of grooves 26 at opposite ends of the rib portion.
- the grooves 26 and the enlarged first and second end portions 16 and 18 are used to aid the surgeon in suturing and securing the enhancement device 10 to the side of the eye.
- FIG. 3 an enlarged end view of the enhancement device 10 is shown positioned next to a side of an eye 28 .
- the eye in the drawings is shown in cross section.
- the device 10 is disposed next to a portion of an outer wall 30 of a sclera 32 and a portion of the ciliary body 34 .
- the ciliary body 34 is shown attached to one end of a zonule 36 .
- the device 10 is illustrated with a portion of a suture 38 positioned for attaching it to the sclera 32 .
- FIG. 4 another enlarged end view of the enhancement device 10 is shown with the convex surface 14 compressed against a portion of the sclera 32 and the ciliary body 34 .
- the compression body 11 is shown sutured to the sclera 32 using sutures 38 .
- a key feature of the subject invention is the plane or length of the front 12 of the compression body 11 is disposed parallel to a planer surface of the sclera 32 .
- the planer surface of the sclera 32 is shown along an axis X-X in this drawing.
- both the front 12 and the convex surface 14 compress or buckle inwardly the sclera 32 and the ciliary body 34 .
- the attachment of the device 10 creates a compressive or centripetal force, shown as dashed lines 40 , inwardly toward a vitreous humor 42 in the rear of the eye 28 .
- the compressive force 40 is perpendicular to the axis X-X of the planer surface of the sclera 32 .
- added compressive forces 40 are directed inwardly toward the vitreous humor 38 .
- FIG. 5 an enlarged perspective view and cross-section of the eye 28 is shown and illustrating a line of vision, shown as a dashed line 44 .
- the line of vision 44 is centered on a crystalline eye lens 46 inside an eye lens bag 48 .
- two of the enhancement devices 10 are shown positioned for suturing to the sclera 32 on opposite sides of the eye 28 .
- a cornea 50 of the eye 28 is also shown in the drawing.
- two or more of the devices 10 will be equally spaced around the side of the eye 28 and sutured to the sclera 32 , as shown in the drawings.
- FIG. 6 another enlarged perspective view and cross-section of the eye 28 is shown illustrating the two enhancement devices 10 sutured to a portion of the sclera 32 .
- the devices 10 are disposed parallel to the plane of the sclera 32 , as shown in FIG. 4 , and compressed against the sclera 32 and the ciliary body 34 inwardly, thus creating posterior compressive forces 40 , perpendicular to the plane of the sclera, directed inwardly toward the vitreous humor 42 in the rear of the eye 28 .
- the compressive forces 36 are disposed behind the eye lens 46 and the eye lens bag 48 , these forces in turn are directed upwardly, as shown in the drawing, and parallel to the line of vision 44 .
- This key feature provides for pressure and forward movement, shown as arrows 52 , of the eye lens 46 and the eye lens bag 48 , thus helping prevent and/or treat presbyopia of the eye 28 .
- FIG. 7 a perspective view of a portion of the sclera 32 is shown and illustrating an alternate way of securing the enhancement device 10 to the sclera 12 .
- a pair of sclera flaps 54 are cut in the outer wall 30 of the sclera 32 forming an opening therein.
- the center portion 20 of one of the enhancement devices 10 is now placed next to the opening and sutured to the sclera 32 using sutures 38 .
- sclera flaps 32 While a pair of sclera flaps 32 are shown in this example, it can be appreciated that a single sclera flap 54 can be used equally well for securing the device 10 to the sclera and adding additional compressive force to the sclera and the ciliary body.
- FIG. 8 another perspective view of the portion of the sclera 32 is shown with the sclera flaps 54 folded on top of the center portion 20 of the device 10 and sutured together and tightened downwardly thereon.
- added compressive pressure is applied to the enhancement device 10 for providing additional inward force in buckling and compressing the sclera and the ciliary body.
- the use of the sclera flaps 54 is an alternate procedure when compared to securing the enhancement device 10 to the outer wall 30 of the sclera 32 , as shown in FIGS. 4 and 6 .
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Prostheses (AREA)
Abstract
A reading enhancement device for preventing and/or treating presbyopia of the eye. The enhancement device is sutured to an outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera and exerting a posterior compression force toward the vitreous humor in the rear of the eye. The enhancement device includes a compression body with a front of the body having semi-circular convex surface. The compression body made of a non-metallic, synthetic polymer. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Also, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion. The grooves and the enlarged, rounded first and second end portions are used to aid the eye surgeon in suturing and securing the enhancement device to the side of the eye.
Description
This reissue application of U.S. Pat. No. 8,167,938 is currently involved in pending inter-partes reexamination number 95/002,083, and is a continuation patent application and claims the benefit of a non-provisional patent application Ser. No. 11/267,485 filed on Nov. 5, 2005 now U.S. Pat. No. 7,736,389, which is involved in pending inter-partes reexamination 95/002,082. Application Ser. No. 11/267,485 claims the benefit of an earlier filed non-provisional utility application Ser. No. 11/210,236 filed on Aug. 23, 2005. Application Ser. No. 11/210,236 claims the benefit of an earlier filed provisional application Ser. No. 60/603,965, by the subject inventor and filed on Aug. 23, 2004.
(a) Field of the Invention
This invention relates to a reading enhancement device sutured to the sclera of the eye for preventing and/or treating presbyopia and more particularly, but not by way of limitation, to a reading enhancement device for suturing to the outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera.
Presbyopia is well known as a reduction or loss of nearsight, usually present in the fourth or fifth decade of a person's age. The subject enhancement device exerts a posterior compressive force or centripetal force directed toward the vitreous humor in the rear of the eye and behind the crystalline eye lens and eye lens bag. The compressive force is perpendicular to the plane of the sclera and provides for movement of the eye lens and eye lens bag forward along a line of vision for the correction of presbyopia.
(b) Discussion of Prior Art
Heretofore, a number of differing theories have been described as to the physiology of the contraction of the ciliary body or ciliary muscle and tension on the zonule connected to the eye lens for the forward movement of the lens for the correction of presbyopia. For example, in U.S. Pat. Nos. 5,354,331, 5,465,737, 5,489,299 and 6,007,578 to Schachar, a theory for correcting for presbyopia is disclosed wherein the zonule ligament is placed in tension for flattening the periphery of the eye lens and creating a convex projection of the center of the lens.
In U.S. Pat. No. 6,682,560 to Baikoff, an element for correcting presbyopia is described. The corrective element is implanted in a tunnel in the sclera and in line with the ciliary body of the eye. The element has a geometric design for exerting a centripetal force on the ciliary body at an angle perpendicular to the optical axis of the eye. While this type of corrective design can be used for treating phakic individuals, it will have no effect on treating pseudophakic individuals. Also in the patent to Baikoff, the corrective element includes a rear wall for providing a pressure force oriented toward the center and the rear of the eye. This feature ensures compression of the vitreous humor and induces pressure and movement of the lens forwardly. While, the corrective element of Baikoff is somewhat similar to the subject invention, the Baikoff patent doesn't disclose or teach the importance of a reading enhancement device sutured to the outer wall of the sclera for directing an inward posterior compressive force perpendicular to the plane of the outer wall of the sclera. This key feature allows for the posterior compressive force to be directed behind the crystalline eye lens and eye lens bag for forward movement of the eye lens. The forward movement of the eye lens correcting for nearsight and based on a theory advocated by Van Helmholtz.
None of the above mentioned prior art patents specifically disclose the unique features, structure and function of the subject reading enhancement device sutured to the outer wall of the sclera for preventing and/or treating presbyopia of the eye as disclosed herein.
In view of the foregoing, it is a primary objective of the subject invention to provide an eye surgeon with a procedure for preventing and/or treating presbyopa of the eye for both phakic and pseudophakic individuals.
Another object of the invention is to create posterior compressive forces perpendicular to a plane of the sclera and directed inwardly and readwardly behind the crystalline eye lens and eye lens bag for forward movement of the eye lens.
Still another object of the reading enhancement device is the device's compression body is sutured directly to the outer wall of the sclera, so that a surgical incision in the sclera isn't necessary. This non-invasive procedure reduces the risk of infection and the length and cost of surgery. Also, because of this type of non-invasive procedure, there is less post operative pain and/or swelling and recovery time is reduced.
Yet another object of the invention is the procedure doesn't create adverse eye effects such as capillary constriction, necrosis and macular edema. Also, the use of one or more of the reading enhancement devices is completely reversible with no long term adverse consequences.
Further, the present invention may be used for one or both eyes with one or more of the devices evenly spaced around the iris at the junction of the pars plana and the ora serrata. The enhancement devices may vary in size and thickness for correcting for varying amounts of functional loss. For example, a thicker device can be used to correct vision of a person with 3 diopters of loss and a thinner device can be used to correct the vision of a person with 1 diopter of loss.
The subject reading enhancement device includes a compression body with a front of the body having semi-circular convex surface. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Further, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion. The grooves and the enlarged, rounded first and second end portions are used to aid the eye surgeon in suturing and securing the enhancement device to the side of the eye.
These and other objects of the present invention will become apparent to those in the medical profession familiar with various devices, methods and procedures for correcting for presbyopia when reviewing the following detailed description, showing novel construction, combination, and elements as herein described, and more particularly defined by the claims, it being understood that changes in the embodiments to the herein disclosed invention are meant to be included as coming within the scope of the claims, except insofar as they may be precluded by the prior art.
The accompanying drawings illustrate preferred embodiments in the present invention according to the best modes presently devised for the practical application of the principles thereof, and in which:
In FIG. 1 , a front view of the enlarged subject reading enhancement device is shown having general reference numeral 10. The enhancement device 10 includes a compression body 11 with an “I-beam” configuration. A front 12 of the compression body 11 includes an outwardly extending semi-circular convex surface 14. A side profile of the convex surface 14 is shown in FIG. 2 . The convex surface 14 is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body 11 also includes an enlarged, rounded first end portion 16, an enlarged, rounded second end portion 18 and an elongated center portion 20 with the convex surface 14 formed thereon.
The enhancement device 10 typically has a length “L” in a range of 3 to 6 mm, a width “W” of 0.5 to 2.0 mm, a width “W1” of 1.0 to 3.0 mm and a thickness “T”, shown in FIG. 2 , of the center portion 20 of 0.3 to 1.0 mm. Obviously, these dimension will vary depending on the eye application and method of engaging the side of the eye. Also, the device 10 can be made of either metallic or non-metallic materials, one or more different types of material, and treated with anti-infective or anti-inflammatory agents.
In FIG. 2 , a side view of the enlarged enhancement device 10 is shown. In this drawing, the compression body 11 is shown with a rear 22 having an outwardly extending rib portion 24 having a pair of grooves 26 at opposite ends of the rib portion. The grooves 26 and the enlarged first and second end portions 16 and 18 are used to aid the surgeon in suturing and securing the enhancement device 10 to the side of the eye.
In FIG. 3 , an enlarged end view of the enhancement device 10 is shown positioned next to a side of an eye 28. The eye in the drawings is shown in cross section. In this view, the device 10 is disposed next to a portion of an outer wall 30 of a sclera 32 and a portion of the ciliary body 34. The ciliary body 34 is shown attached to one end of a zonule 36. In this drawing, the device 10 is illustrated with a portion of a suture 38 positioned for attaching it to the sclera 32.
In FIG. 4 , another enlarged end view of the enhancement device 10 is shown with the convex surface 14 compressed against a portion of the sclera 32 and the ciliary body 34. The compression body 11 is shown sutured to the sclera 32 using sutures 38. It should be noted that a key feature of the subject invention is the plane or length of the front 12 of the compression body 11 is disposed parallel to a planer surface of the sclera 32. The planer surface of the sclera 32 is shown along an axis X-X in this drawing.
When the device 10 has been properly sutured to the sclera 32 and along the length of the sclera, both the front 12 and the convex surface 14 compress or buckle inwardly the sclera 32 and the ciliary body 34. The attachment of the device 10 creates a compressive or centripetal force, shown as dashed lines 40, inwardly toward a vitreous humor 42 in the rear of the eye 28. It should be noted that the compressive force 40 is perpendicular to the axis X-X of the planer surface of the sclera 32. Also, by the nature of the sutures 38 attached to the sclera 32, added compressive forces 40 are directed inwardly toward the vitreous humor 38.
In FIG. 5 , an enlarged perspective view and cross-section of the eye 28 is shown and illustrating a line of vision, shown as a dashed line 44. The line of vision 44 is centered on a crystalline eye lens 46 inside an eye lens bag 48. In this drawing, two of the enhancement devices 10 are shown positioned for suturing to the sclera 32 on opposite sides of the eye 28. Also shown in the drawing is a cornea 50 of the eye 28. For proper balance of the compression forces 40 to the rear of the eye 28, two or more of the devices 10 will be equally spaced around the side of the eye 28 and sutured to the sclera 32, as shown in the drawings.
In FIG. 6 , another enlarged perspective view and cross-section of the eye 28 is shown illustrating the two enhancement devices 10 sutured to a portion of the sclera 32. The devices 10 are disposed parallel to the plane of the sclera 32, as shown in FIG. 4 , and compressed against the sclera 32 and the ciliary body 34 inwardly, thus creating posterior compressive forces 40, perpendicular to the plane of the sclera, directed inwardly toward the vitreous humor 42 in the rear of the eye 28. Because the compressive forces 36 are disposed behind the eye lens 46 and the eye lens bag 48, these forces in turn are directed upwardly, as shown in the drawing, and parallel to the line of vision 44. This key feature provides for pressure and forward movement, shown as arrows 52, of the eye lens 46 and the eye lens bag 48, thus helping prevent and/or treat presbyopia of the eye 28.
In FIG. 7 , a perspective view of a portion of the sclera 32 is shown and illustrating an alternate way of securing the enhancement device 10 to the sclera 12. In this example, a pair of sclera flaps 54 are cut in the outer wall 30 of the sclera 32 forming an opening therein. The center portion 20 of one of the enhancement devices 10 is now placed next to the opening and sutured to the sclera 32 using sutures 38. While a pair of sclera flaps 32 are shown in this example, it can be appreciated that a single sclera flap 54 can be used equally well for securing the device 10 to the sclera and adding additional compressive force to the sclera and the ciliary body.
In FIG. 8 , another perspective view of the portion of the sclera 32 is shown with the sclera flaps 54 folded on top of the center portion 20 of the device 10 and sutured together and tightened downwardly thereon. In this manner and using this procedure, added compressive pressure is applied to the enhancement device 10 for providing additional inward force in buckling and compressing the sclera and the ciliary body. Obviously, the use of the sclera flaps 54 is an alternate procedure when compared to securing the enhancement device 10 to the outer wall 30 of the sclera 32, as shown in FIGS. 4 and 6 .
While the invention has been particularly shown, described and illustrated in detail with reference to the preferred embodiments and modifications thereof, it should be understood by those skilled in the art that equivalent changes in form and detail may be made therein without departing from the true spirit and scope of the invention as claimed except as precluded by the prior art.
Claims (16)
1. A suture device for preventing and/or treating presbyopia of the eye, the suture device configured for suturing to the outer wall of the sclera to effect buckling and compressing a portion of the sclera, the suture device having a convex portion shaped to force the ciliary body inwardly thereby exerting a posterior compression force perpendicular to the sclera wherein the compression force strengthens the muscle of the ciliary body by reducing the stretching of the scleral spur occurring with age, the suture device comprising:
an I-beam shaped compression body having an elongated semi-circular convex center portion, the center portion of the I-beam shaped compression body terminating in transverse first and second ends, wherein the first end is adapted for receiving a first suture thereon and the second end is adapted for receiving a second suture thereon, wherein each of the first and second ends have a configuration preventing the first and second sutures from slipping off the center portion respectively; and
the convex center portion having a tissue engaging surface extending outwardly from a front of the convex center portion and extending between the transverse first and second ends, the tissue engaging surface made of a compressible material, the compressible material reducing direct pressure on the blood vessels and nerves of the eye when engaging the outer wall of the sclera;
whereby when the transverse first end is sutured to the outer wall of the sclera using the first suture and the transverse second end is sutured to the outer wall of the sclera using the second suture, the tissue engaging surface of the semi-circular convex center portion is compressed against a portion of the outer wall of the sclera thereby exerting a compression force to the sclera.
2. The suture device as described in claim 1 wherein the compressible material of the tissue engaging surface is made of non-metallic, synthetic polymer.
3. The suture device as described in claim 1 wherein the compression body is treated with an anti-infective agent.
4. The suture device as described in claim 1 wherein the compression body is treated with an anti-inflammatory agent.
5. The suture device as described in claim 1 wherein the compression body includes a rib portion extending outwardly from a back of the center portion, opposite ends of the rib portion include a groove therein, the two grooves adapted for receiving the first and second sutures thereon.
6. The suture device as described in claim 1 wherein the compression body has a length “L” in a range of 3 to 6 mm, a width “W” in a range of 0.5 to 2.0 mm and a thickness “T” in a range of 0.3 to 1.0 mm.
7. A suture device for preventing and/or treating presbyopia of the eye, the suture device configured for suturing to the outer wall of the sclera to effect buckling and compressing a portion of the sclera, the suture device having a convex portion shaped to force the ciliary body inwardly thereby exerting a posterior compression force perpendicular to the sclera wherein the compression force strengthens the muscle of the ciliary body by reducing the stretching of the scleral spur occurring with age, the suture device comprising:
an I-beam shaped compression body having an elongated semi-circular convex center portion, the center portion of the I-beam shaped compression body terminating in transverse first and second ends, wherein the first end is adapted for receiving a first suture thereon and the second end is adapted for receiving a second suture thereon, wherein each of the first and second ends have a configuration preventing the first and second sutures from slipping off the center portion respectively;
the convex center portion having a tissue engaging surface extending outwardly from a front of the convex center portion and extending between the transverse first and second ends, the convex center portion made of a first material and the tissue engaging surface made of a second material, and
a rib portion extending outwardly from a back of the convex center portion, opposite ends of the rib portion include a groove therein, the two grooves adapted for receiving the first and second sutures thereon;
whereby when the transverse first end is sutured to the outer wall of the sclera using the first suture and the transverse second end is sutured to the outer wall of the sclera using the second suture, the tissue engaging surface of the semi-circular convex center portion is compressed against a portion of the outer wall of the sclera thereby exerting a compression force to the sclera.
8. The suture device as described in claim 7 wherein the first and second materials are made of a non-metallic material.
9. The suture device as described in claim 7 wherein the first material is made of a hard, rigid material for maintaining the overall shape of the compression body and wherein the second material is made of a compressible material, the compressible material reducing direct pressure on the blood vessels and nerves of the eye when engaging the outer wall of the sclera.
10. The suture device as described in claim 7 wherein the compression body is treated with an anti-infective agent.
11. The suture device as described in claim 7 wherein the compression body is treated with an anti-inflammatory agent.
12. The suture device as described in claim 7 wherein the compression body has a length “L” in a range of 3 to 6 mm, a width “W” in a range of 0.5 to 2.0 mm and a thickness “T” in a range of 0.3 to 1.0 mm.
13. A suture device for preventing and/or treating presbyopia of the eye, the suture device configured for suturing to the outer wall of the sclera to effect buckling and compressing a portion of the sclera, the suture device having a convex portion shaped to force the ciliary body inwardly thereby exerting a posterior compression force perpendicular to the sclera wherein the compression force strengthens the muscle of the ciliary body by reducing the stretching of the scleral spur occurring with age, the suture device comprising:
an I-beam shaped compression body having an elongated semi-circular convex center portion, the center portion of the I-beam shaped compression body terminating in transverse first and second ends, wherein the first end is adapted for receiving a first suture thereon and the second end is adapted for receiving a second suture thereon, wherein each of the first and second ends have a configuration preventing the first and second sutures from slipping off the center portion respectively;
the convex center portion having a tissue engaging surface extending outwardly from a front of the convex center portion and extending between the transverse first and second ends, the convex center portion made of a first non-metallic material and the tissue engaging surface made of a second non-metallic material, the first material is made of a hard, rigid material for maintaining the overall shape of the compression body, the second material is made of a compressible material for reducing direct pressure on the blood vessels and nerves of the eye when engaging the outer wall of the sclera; and
a rib portion extending outwardly from a back of the convex center portion, opposite ends of the rib portion include a groove therein, the two grooves adapted for receiving the first and second sutures thereon;
whereby when the transverse first end is sutured to the outer wall of the sclera using the first suture and the transverse second end is sutured to the outer wall of the sclera using the second suture, the tissue engaging surface of the convex center portion is compressed against a portion of the outer wall of the sclera thereby exerting a compression force to the sclera.
14. The suture device as described in claim 13 wherein the compression body is treated with an anti-infective agent.
15. The suture device as described in claim 13 wherein the compression body is treated with an anti-inflammatory agent.
16. The suture device as described in claim 13 wherein the compression body has a length “L” in a range of 3 to 6 mm, a width “W” in a range of 0.5 to 2.0 mm and a thickness “T” in a range of 0.3 to 1.0 mm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/266,677 USRE45625E1 (en) | 2004-08-23 | 2014-04-30 | Reading enhancement device for preventing and treating presbyopia of the eye |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60396504P | 2004-08-23 | 2004-08-23 | |
US21023605A | 2005-08-23 | 2005-08-23 | |
US11/267,485 US7736389B1 (en) | 2004-08-23 | 2005-11-05 | Reading enhancement device for preventing and treating presbyopia of the eye |
US12/799,643 US8167938B1 (en) | 2005-11-05 | 2010-04-29 | Reading enhancement device for preventing and treating presbyopia of the eye |
US14/266,677 USRE45625E1 (en) | 2004-08-23 | 2014-04-30 | Reading enhancement device for preventing and treating presbyopia of the eye |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/799,643 Reissue US8167938B1 (en) | 2004-08-23 | 2010-04-29 | Reading enhancement device for preventing and treating presbyopia of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE45625E1 true USRE45625E1 (en) | 2015-07-28 |
Family
ID=45990782
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/267,485 Active 2028-05-09 US7736389B1 (en) | 2004-08-23 | 2005-11-05 | Reading enhancement device for preventing and treating presbyopia of the eye |
US12/799,643 Ceased US8167938B1 (en) | 2004-08-23 | 2010-04-29 | Reading enhancement device for preventing and treating presbyopia of the eye |
US14/266,677 Expired - Fee Related USRE45625E1 (en) | 2004-08-23 | 2014-04-30 | Reading enhancement device for preventing and treating presbyopia of the eye |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/267,485 Active 2028-05-09 US7736389B1 (en) | 2004-08-23 | 2005-11-05 | Reading enhancement device for preventing and treating presbyopia of the eye |
US12/799,643 Ceased US8167938B1 (en) | 2004-08-23 | 2010-04-29 | Reading enhancement device for preventing and treating presbyopia of the eye |
Country Status (1)
Country | Link |
---|---|
US (3) | US7736389B1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008008366A2 (en) | 2006-07-11 | 2008-01-17 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
US8911496B2 (en) | 2006-07-11 | 2014-12-16 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
EP2892465B1 (en) | 2012-09-07 | 2020-12-23 | Robert Park | Eye shape modification systems |
US9763772B1 (en) * | 2015-06-18 | 2017-09-19 | Richard Damiano | Reading enhancement device for preventing and treating presbyopia of the eye |
US10548713B2 (en) * | 2017-05-24 | 2020-02-04 | Visioncare, Inc. | Intraocular lens including scleral engagement portion |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354331A (en) | 1992-07-15 | 1994-10-11 | Schachar Ronald A | Treatment of presbyopia and other eye disorders |
US5465737A (en) | 1992-07-15 | 1995-11-14 | Schachar; Ronald A. | Treatment of presbyopia and other eye disorders |
US6007578A (en) | 1997-10-08 | 1999-12-28 | Ras Holding Corp | Scleral prosthesis for treatment of presbyopia and other eye disorders |
WO2001017460A1 (en) | 1999-09-03 | 2001-03-15 | Restorvision, Inc. | Ophthalmic device and method of manufacture and use |
US6214044B1 (en) | 1992-08-07 | 2001-04-10 | Keravision, Inc. | Hybrid intrastromal corneal ring |
US20020002403A1 (en) | 1997-10-08 | 2002-01-03 | Zdenek Gene W. | Scleral expansion device having duck bill |
US6682560B1 (en) | 2001-01-19 | 2004-01-27 | Georges Baikoff | Element correcting presbyopia |
US6712847B2 (en) | 1998-10-13 | 2004-03-30 | O.I.I. International, Inc. | Scleral expansion segment |
US20040098126A1 (en) | 2002-11-19 | 2004-05-20 | Eagle Vision, Inc. | Ridged scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
US20060004386A1 (en) | 2004-07-01 | 2006-01-05 | Caro Nicholas C | Ophthalmic clip and associated surgical method |
US20080091266A1 (en) | 2006-07-11 | 2008-04-17 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
US7416560B1 (en) | 1999-06-07 | 2008-08-26 | Refocus Ocular, Inc. | Scleral prosthesis for treatment of presbyopia and other eye disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4750904A (en) * | 1986-03-31 | 1988-06-14 | Price Jr Francis W | Posterior chamber intraocular lens with improved fixation where the posterior capsule is not present to serve as a fixation platform |
US5127901A (en) * | 1990-05-18 | 1992-07-07 | Odrich Ronald B | Implant with subconjunctival arch |
US6218360B1 (en) * | 1998-11-19 | 2001-04-17 | The Schepens Eye Research Institute | Collagen based biomaterials and methods of preparation and use |
US6200342B1 (en) * | 1999-05-11 | 2001-03-13 | Marie-Jose B. Tassignon | Intraocular lens with accommodative properties |
WO2002076356A2 (en) * | 2001-03-22 | 2002-10-03 | Newlens, Llc | Presbyopia treatment by scleral compression |
US6737448B2 (en) * | 2002-06-03 | 2004-05-18 | Staar Surgical Company | High refractive index, optically clear and soft hydrophobic acrylamide copolymers |
US20040098124A1 (en) * | 2002-11-19 | 2004-05-20 | Freeman Jerre M. | Elongate scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
US7341599B1 (en) * | 2003-04-09 | 2008-03-11 | Minu, Llc | Intraocular lens for correcting presbyopia |
-
2005
- 2005-11-05 US US11/267,485 patent/US7736389B1/en active Active
-
2010
- 2010-04-29 US US12/799,643 patent/US8167938B1/en not_active Ceased
-
2014
- 2014-04-30 US US14/266,677 patent/USRE45625E1/en not_active Expired - Fee Related
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5465737A (en) | 1992-07-15 | 1995-11-14 | Schachar; Ronald A. | Treatment of presbyopia and other eye disorders |
US5489299A (en) | 1992-07-15 | 1996-02-06 | Schachar; Ronald A. | Treatment of presbyopia and other eye disorders |
US5354331A (en) | 1992-07-15 | 1994-10-11 | Schachar Ronald A | Treatment of presbyopia and other eye disorders |
US6214044B1 (en) | 1992-08-07 | 2001-04-10 | Keravision, Inc. | Hybrid intrastromal corneal ring |
US6280468B1 (en) | 1997-10-08 | 2001-08-28 | Ras Holding Corp | Scleral prosthesis for treatment of presbyopia and other eye disorders |
US6007578A (en) | 1997-10-08 | 1999-12-28 | Ras Holding Corp | Scleral prosthesis for treatment of presbyopia and other eye disorders |
US20020002403A1 (en) | 1997-10-08 | 2002-01-03 | Zdenek Gene W. | Scleral expansion device having duck bill |
US6712847B2 (en) | 1998-10-13 | 2004-03-30 | O.I.I. International, Inc. | Scleral expansion segment |
US7416560B1 (en) | 1999-06-07 | 2008-08-26 | Refocus Ocular, Inc. | Scleral prosthesis for treatment of presbyopia and other eye disorders |
WO2001017460A1 (en) | 1999-09-03 | 2001-03-15 | Restorvision, Inc. | Ophthalmic device and method of manufacture and use |
US6682560B1 (en) | 2001-01-19 | 2004-01-27 | Georges Baikoff | Element correcting presbyopia |
US20040098126A1 (en) | 2002-11-19 | 2004-05-20 | Eagle Vision, Inc. | Ridged scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
US20060004386A1 (en) | 2004-07-01 | 2006-01-05 | Caro Nicholas C | Ophthalmic clip and associated surgical method |
US20080091266A1 (en) | 2006-07-11 | 2008-04-17 | Refocus Group, Inc. | Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods |
Non-Patent Citations (1)
Title |
---|
U.S. Appl. No. 60/819,995, filed Jul. 11, 2006. |
Also Published As
Publication number | Publication date |
---|---|
US8167938B1 (en) | 2012-05-01 |
US7736389B1 (en) | 2010-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE45625E1 (en) | Reading enhancement device for preventing and treating presbyopia of the eye | |
US7338506B2 (en) | Scleral clip and procedures for using same | |
AU2001289189B2 (en) | Scleral clip and procedures for using same | |
US5078740A (en) | Intraocular lens | |
DE60307816T2 (en) | AKKOMMODATIVE INTRAOCULAR LENS | |
US4575878A (en) | Intraocular lenses | |
US10064717B2 (en) | Retinal repair device and method | |
US20020193877A1 (en) | Foldable iris fixated intraocular lenses | |
AU2001289189A1 (en) | Scleral clip and procedures for using same | |
US20020123804A1 (en) | Scleral implants for treating presbyopia and methods for implanting the same | |
Shugar et al. | Implantation of multiple foldable acrylic posterior chamber lenses in the capsular bag for high hyperopia | |
US20140074234A1 (en) | Scleral Epimacular Implant | |
US20190053889A1 (en) | Artificial iris having pouch | |
US9763772B1 (en) | Reading enhancement device for preventing and treating presbyopia of the eye | |
US20060004387A1 (en) | Ophthalmic clip and associated surgical method | |
US20070142911A1 (en) | Refractive intraocular implant lens and method | |
WO2011155916A1 (en) | A reading enhancement device for preventing and treating presbyopia of the eye | |
WO2007076533A2 (en) | Ophthalmic clip and associated surgical method | |
US11160649B2 (en) | Flexible integral intracorneal ring | |
Bissell et al. | Bilateral geographic atrophy: spontaneous visual improvement after loss of vision in the fellow eye | |
JPH02189146A (en) | Contact lens | |
RU2266087C1 (en) | Surgical device for treating the cases of keratoconus | |
US20070142912A1 (en) | Refractive intraocular implant lens and method | |
Gorbunova et al. | First experience of implantation of extended depth of focus intraocular lenses in patients with glaucoma | |
RU2028129C1 (en) | Method of treating progressive myopia aggravated by exophoria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |